Product Description: JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis[1].
Applications: Cancer-programmed cell death
Formula: C16H15NO4S
References: [1]Xuehui Long, et al. Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity. Nat Immunol. 2024.